{"nct_id":"NCT00341055","title":"A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.","status":"COMPLETED","status_verified_date":"2010-03","start_date":"2003-06","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2004-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}